Lasocki et al. further corroborated that solid enhancement on MRI is an adverse prognostic indicator in IDH-mutant astrocytomas, remaining significant even on multivariate analysis, whereas molecular factors like CDKN2A/B deletion only showed modest survival effects [28]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).